Glenmede Trust Co. NA increased its holdings in shares of Agilent Technologies Inc (NYSE:A) by 4.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 447,884 shares of the medical research company’s stock after purchasing an additional 19,716 shares during the period. Glenmede Trust Co. NA owned 0.14% of Agilent Technologies worth $27,697,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in A. BlackRock Inc. increased its holdings in shares of Agilent Technologies by 10.8% in the 1st quarter. BlackRock Inc. now owns 28,445,160 shares of the medical research company’s stock valued at $1,902,983,000 after purchasing an additional 2,779,802 shares in the last quarter. OppenheimerFunds Inc. increased its holdings in shares of Agilent Technologies by 64.0% in the 2nd quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock valued at $472,248,000 after purchasing an additional 2,980,216 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of Agilent Technologies by 30.3% in the 2nd quarter. American Century Companies Inc. now owns 4,585,162 shares of the medical research company’s stock valued at $283,546,000 after purchasing an additional 1,065,877 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of Agilent Technologies by 6.6% in the 2nd quarter. Wells Fargo & Company MN now owns 2,984,214 shares of the medical research company’s stock valued at $184,544,000 after purchasing an additional 183,728 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. purchased a new position in shares of Agilent Technologies in the 1st quarter valued at about $100,067,000.
A has been the subject of several recent research reports. ValuEngine upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Wednesday, July 25th. Morgan Stanley raised their price target on shares of Agilent Technologies from $83.00 to $84.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 15th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research note on Tuesday, August 7th. Goldman Sachs Group reaffirmed a “buy” rating and set a $82.00 price target (up from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. Finally, Deutsche Bank raised their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, August 15th. Ten research analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and a consensus target price of $77.44.
In other news, Director Paul N. Clark sold 2,876 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $68.60, for a total transaction of $197,293.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Heidi Fields sold 5,482 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $67.73, for a total transaction of $371,295.86. The disclosure for this sale can be found here.
Shares of A traded up $1.35 during mid-day trading on Friday, hitting $66.24. The company had a trading volume of 3,666,085 shares, compared to its average volume of 2,537,062. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.00 and a current ratio of 3.62. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $75.00. The stock has a market capitalization of $22.49 billion, a PE ratio of 28.07, a P/E/G ratio of 2.42 and a beta of 1.32.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.04. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period last year, the company earned $0.59 earnings per share. The company’s quarterly revenue was up 8.0% on a year-over-year basis. As a group, sell-side analysts expect that Agilent Technologies Inc will post 2.71 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd will be given a dividend of $0.149 per share. The ex-dividend date of this dividend is Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a yield of 0.90%. Agilent Technologies’s dividend payout ratio (DPR) is 25.42%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: Average Daily Trade Volume Explained
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.